K. Nadine Phoa
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia: A Randomized Clinical Trial
Phoa, K. Nadine; van Vilsteren, Frederike G.I.; Weusten, Bas L.A.M.; Bisschops, Raf; Schoon, Erik J.; Raganuth, Krish; Fullarton, Grant; Di Pietro, Massimiliano; Ravi, Narayanasamy; Visser, Mike; Offerhaus, G. Johan; Seldenrijk, Cees A.; Meijer, Sybren L.; ten Kate, Fiebo J.W.; Tijssen, Jan G.P.; Bergman, Jacques J.G.H.M.
Authors
Frederike G.I. van Vilsteren
Bas L.A.M. Weusten
Raf Bisschops
Erik J. Schoon
Krish Raganuth
Grant Fullarton
Massimiliano Di Pietro
Narayanasamy Ravi
Mike Visser
G. Johan Offerhaus
Cees A. Seldenrijk
Sybren L. Meijer
Fiebo J.W. ten Kate
Jan G.P. Tijssen
Jacques J.G.H.M. Bergman
Abstract
Importance
Barrett esophagus containing low-grade dysplasia is associated with an increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly increasing incidence in the western world.
Objective
To investigate whether endoscopic radiofrequency ablation could decrease the rate of neoplastic progression.
Design, Setting, and Participants
Multicenter randomized clinical trial that enrolled 136 patients with a confirmed diagnosis of Barrett esophagus containing low-grade dysplasia at 9 European sites between June 2007 and June 2011. Patient follow-up ended May 2013.
Interventions
Eligible patients were randomly assigned in a 1:1 ratio to either endoscopic treatment with radiofrequency ablation (ablation) or endoscopic surveillance (control). Ablation was performed with the balloon device for circumferential ablation of the esophagus or the focal device for targeted ablation, with a maximum of 5 sessions allowed.
Main Outcomes and Measures
The primary outcome was neoplastic progression to high-grade dysplasia or adenocarcinoma during a 3-year follow-up since randomization. Secondary outcomes were complete eradication of dysplasia and intestinal metaplasia and adverse events.
Results
Sixty-eight patients were randomized to receive ablation and 68 to receive control. Ablation reduced the risk of progression to high-grade dysplasia or adenocarcinoma by 25.0% (1.5% for ablation vs 26.5% for control; 95% CI, 14.1%-35.9%; P?
Citation
Phoa, K. N., van Vilsteren, F. G., Weusten, B. L., Bisschops, R., Schoon, E. J., Raganuth, K., Fullarton, G., Di Pietro, M., Ravi, N., Visser, M., Offerhaus, G. J., Seldenrijk, C. A., Meijer, S. L., ten Kate, F. J., Tijssen, J. G., & Bergman, J. J. (2014). Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia: A Randomized Clinical Trial. Journal of the American Medical Association, 311(12), 1209-1217. https://doi.org/10.1001/jama.2014.2511
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 28, 2014 |
Online Publication Date | Mar 26, 2014 |
Publication Date | Mar 26, 2014 |
Deposit Date | Feb 12, 2018 |
Publicly Available Date | Dec 16, 2020 |
Journal | Journal of the American Medical Association |
Print ISSN | 0098-7484 |
Electronic ISSN | 1538-3598 |
Publisher | American Medical Association |
Peer Reviewed | Peer Reviewed |
Volume | 311 |
Issue | 12 |
Pages | 1209-1217 |
DOI | https://doi.org/10.1001/jama.2014.2511 |
Public URL | https://nottingham-repository.worktribe.com/output/1118264 |
Publisher URL | https://jamanetwork.com/article.aspx?doi=10.1001/jama.2014.2511 |
PMID | 24668102 |
Files
SURF R1 JAMA 6Feb2014 Clean
(353 Kb)
PDF
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search